New therapy option for CAP and HAP

Zevtera® (Ceftobiprole medocaril): the latest generation Cephalosporin with broad-spectrum of activity launches in the UK

Source: Pharmacy Europe - July 9, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Industry News Drug development Therapeutic drug monitoring Drug discovery Infectious Disease Patient care AMR antimicrobial resistance broad-spectrum antibiotics cap Cephal Source Type: news